---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-198768"
form_type: "8-K"
ticker: "TCRX"
cik: "0001783328"
company_name: "TScan Therapeutics, Inc."
filed_at: "2025-09-09T23:59:59+00:00"
generated_at: "2026-05-17T07:20:14.603912+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# TScan Therapeutics updates corporate presentation with adjusted timelines and pipeline updates

## Summary
- Company furnished updated corporate presentation on September 9, 2025 for investor meetings.
- Presentation includes adjusted timelines for solid tumor program and pipeline updates across hematologic malignancies and solid tumors.
- Updates on target discovery initiatives in autoimmunity also included; specific numerical details not disclosed in filing.

## SEC filing metadata
- accession: 0001193125-25-198768
- form_type: 8-K
- ticker: TCRX
- cik: 0001783328
- company_name: TScan Therapeutics, Inc.
- filed_at: 2025-09-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783328/000119312525198768/0001193125-25-198768-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783328/000119312525198768/d125738d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-198768
- JSON: https://secwatch.observer/filing/0001193125-25-198768.json
- Plain text: https://secwatch.observer/filing/0001193125-25-198768.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.